ميمپارا

País: Israel

Idioma: árabe

Fuente: Ministry of Health

Ingredientes activos:

CINACALCET HYDROCHLORIDE 30 MG

Disponible desde:

AMGEN EUROPE B.V.

Código ATC:

H05BX01

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

AMGEN EUROPE B.V., NETHERLANDS

Grupo terapéutico:

CINACALCET

indicaciones terapéuticas:

Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.

Fecha de autorización:

2012-10-01